DEBx Medical is excited to present a special Biofilm session at the Polish 2nd Online Wound Treatment conference with Prof Gregory Schulz and B.J. Quint on the 24th of Sept at 18hrs.
The session will explain the impact of the biofilm in developing chronic wounds and showcase how our new treatment DEBRICHEM® is able to desiccate the biofilm and infection through several case studies.
Visit their website to see the full program.
Our novel debriding agent, DEBRICHEM®, has recently been featured in a 3 article supplement in the Journal of Wound Care. The articles provide an introduction
TVM Capital Healthcare Announces Euro 10 Million Investment in DEBx Medical DEBx Medical is innovating the management of chronic wounds, improving the life of millions
We are excited to announce that our latest paper, “Combining an Acidic Compound and NPWT: Debridement and Granulation in Leg and Foot Ulcers”, has recently
A new peer-reviewed paper on our novel debriding agent DEBRICHEM® was published in the October edition of the Journal of Wound Care. The article is
At the end of this week, DEBx Medical will participate in the Commonwealth and 4th Global Wound Conference at the Sunway Pyramid Convention Center in
